Stock Earnings

Question 1

Phathom Pharmaceuticals Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Phathom Pharmaceuticals Incの総資産は$378で、純lossは$-334です。

Question 2

PHATの主要な財務比率は何ですか？

Accepted Answer

Phathom Pharmaceuticals Incの流動比率は0.59、純利益率は-607.27、1株当たり売上高は$0.87です。

Question 3

Phathom Pharmaceuticals Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Phathom Pharmaceuticals Inc largest revenue segment is Vonoprazan, at a revenue of 55,252,000 in the most earnings release.For geography, United States is the primary market for Phathom Pharmaceuticals Inc, at a revenue of 55,252,000.

Question 4

Phathom Pharmaceuticals Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Phathom Pharmaceuticals Incの純lossは$-334です。

Question 5

Phathom Pharmaceuticals Incに負債はありますか？

Accepted Answer

yes、Phathom Pharmaceuticals Incの負債は631です。

Question 6

Phathom Pharmaceuticals Incの発行済株式数は何株ですか？

Accepted Answer

Phathom Pharmaceuticals Incの総発行済株式数は68.51株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	147	55	0	0	0	0
Revenue Growth (YoY)	465%	--	--	--	--	--
Cost of Revenue	18	7	0	--	--	--
Gross Profit	128	47	0	--	--	--
Selling, General & Admin	308	290	117	101	62	27
Research & Development	33	34	49	71	72	98
Operating Expenses	341	324	167	172	135	125
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-274	-334	-201	-197	-143	-129
Income Tax Expense	--	--	--	--	--	--
Net Income	-274	-334	-201	-197	-143	-129
Net Income Growth	-19%	66%	2%	38%	11%	-49%
Shares Outstanding (Diluted)	73.39	63.17	51.28	39.12	30.51	33.23
Shares Change (YoY)	14%	23%	31%	28%	-8%	34%
EPS (Diluted)	-3.74	-5.29	-3.93	-5.05	-4.72	-3.88
EPS Growth	-28.99%	35%	-22%	7%	22%	-62%
Free Cash Flow	-225	-266	-139	-147	-148	-70
Free Cash Flow Per Share	-3.06	-4.21	-2.71	-3.75	-4.85	-2.1
Gross Margin	87.07%	85.45%	0%	--	--	--
Operating Margin	-144.89%	-503.63%	0%	0%	0%	0%
Profit Margin	-186.39%	-607.27%	0%	0%	0%	0%
Free Cash Flow Margin	-153.06%	-483.63%	0%	0%	0%	0%
EBITDA	-213	-277	-167	-172	-135	-125
EBITDA Margin	-144.89%	-503.63%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-213	-277	-167	-172	-135	-125
EBIT Margin	-144.89%	-503.63%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Phathom Pharmaceuticals Inc (PHAT) Price

PHAT Stock Price Chart

PHAT Income

Follow-Up Questions